PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase
Haihe Wang1, Leah A Vardy, Cheng Peow Tan
1Institute of Molecular and Cell Biology, A*Agency for Science, Technology and Research, 61 Biopolis Drive, Proteos, Singapore 138648, Republic of Singapore.
Abstract:
Overexpression of phosphatase of regenerating liver (PRL)-3 is associated with the progression of diverse human cancers. We show that the overexpression of PRL-3 protein is not directly associated with its transcript levels, indicating the existence of an underlying posttranscriptional regulation. The 5' untranslanted region (UTR) of PRL-3 mRNA possesses triple GCCCAG motifs capable of suppressing mRNA translation through interaction with PolyC-RNA-binding protein 1 (PCBP1), which retards PRL-3 mRNA transcript incorporation into polyribosomes. Overexpression of PCBP1 inhibits PRL-3 expression and inactivates AKT, whereas knockdown of PCBP1 causes upregulation of PRL-3 protein levels, activation of AKT, and promotion of tumorigenesis. An inverse correlation between protein levels of PRL-3 and PCBP1 in human primary cancers supports the clinical relevance.
Insights
Phosphatase of regenerating liver (PRL)-3 protein levels are regulated post-transcriptionally by PolyC-RNA-binding protein 1 (PCBP1) through its 5' untranslated region. This interaction impacts cancer progression and AKT signaling.
Area of Science:
- Molecular Biology
- Cancer Research
- Post-transcriptional Regulation
Background:
- Overexpression of phosphatase of regenerating liver (PRL)-3 is linked to human cancer progression.
- PRL-3 protein levels do not directly correlate with its mRNA transcript levels, suggesting post-transcriptional control.
Purpose of the Study:
- To investigate the post-transcriptional mechanisms regulating PRL-3 expression.
- To identify the role of PolyC-RNA-binding protein 1 (PCBP1) in PRL-3 regulation and its impact on cancer pathways.
Main Methods:
- Analysis of 5' untranslated region (UTR) of PRL-3 mRNA for regulatory elements.
- Investigating the interaction between PRL-3 mRNA and PCBP1.
- Assessing the effects of PCBP1 overexpression and knockdown on PRL-3 protein levels, AKT signaling, and tumorigenesis.
- Correlating PRL-3 and PCBP1 protein levels in human cancer tissues.
Main Results:
- The 5' UTR of PRL-3 mRNA contains triple GCCCAG motifs that bind PCBP1, suppressing translation.
- PCBP1 overexpression inhibits PRL-3 expression and inactivates AKT.
- PCBP1 knockdown leads to increased PRL-3 protein, AKT activation, and promotes tumorigenesis.
- An inverse correlation between PRL-3 and PCBP1 protein levels was observed in human primary cancers.
Conclusions:
- PCBP1 acts as a negative regulator of PRL-3 expression via post-transcriptional mechanisms involving the 5' UTR.
- The PRL-3/PCBP1 axis influences AKT signaling and tumorigenesis, highlighting its clinical relevance in human cancers.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
